Canaccord Genuity Starts Apogee Therapeutics Inc (APGE) at Buy
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $134.55 +0.07%
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash initiates coverage on Apogee Therapeutics Inc (NASDAQ: APGE) with a Buy rating and a price target of $89.00.
For an analyst ratings summary and ratings history on Apogee Therapeutics Inc click here. For more ratings news on Apogee Therapeutics Inc click here.
Shares of Apogee Therapeutics Inc closed at $43.46 yesterday.
You May Also Be Interested In
- Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
